Rapid Micro Biosystems, Inc. (RPID) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Rapid Micro Biosystems, Inc. on March 23, 2022. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Lowell, Massachusetts. Its Class A Common Stock trades on The Nasdaq Global Select Market under the symbol RPID.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director from the Board of Directors. On March 23, 2022, Alexander Schmitz, an independent Class I director and member of the Audit and Compensation Committees, informed the Company that he does not intend to stand for reelection at the 2022 annual meeting of stockholders. Mr. Schmitz will serve out his current term until the Annual Meeting. The Company stated that this decision was not the result of any disagreement regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies related to the director's departure were disclosed, other than the standard note that the departure was not due to disagreement.
Key Facts for Investor Verification
- Alexander Schmitz will not seek reelection as a director at the 2022 annual meeting.
- Mr. Schmitz serves on the Audit Committee and Compensation Committee.
- The departure is voluntary and not attributed to any disagreement with the Company.
- The Company has not announced a replacement candidate in this filing.